Outcomes of the miltuximab first in human trial and proposed study design for a phase 1 trial 89zr/177lu theranostic trial

D. Campbell; D. Sabanathan; H. Gurney; D. Gillatt; M. Trifunovic; P. Poursoultan; K. Ho Shon; T. Mackay; P. Roach; D. Bailey; B. Walsh

doi:10.1016/S1569-9056(19)30637-2

Outcomes of the miltuximab first in human trial and proposed study design for a phase 1 trial 89zr/177lu theranostic trial

D. Campbell, D. Sabanathan, H. Gurney, D. Gillatt, M. Trifunovic, P. Poursoultan, K. Ho Shon, T. Mackay, P. Roach, D. Bailey, B. Walsh

Research output: Contribution to journal › Meeting abstract

Original language	English
Article number	655
Pages (from-to)	e873
Number of pages	1
Journal	European Urology Supplements
Volume	18
Issue number	1
DOIs	https://doi.org/10.1016/S1569-9056(19)30637-2
Publication status	Published - 2019
Event	Annual EAU Congress (34th : 2019) - Barcelona, Spain Duration: 15 Mar 2019 → 19 Mar 2019

Access to Document

10.1016/S1569-9056(19)30637-2

Cite this

Campbell, D., Sabanathan, D., Gurney, H., Gillatt, D., Trifunovic, M., Poursoultan, P., Ho Shon, K., Mackay, T., Roach, P., Bailey, D., & Walsh, B. (2019). Outcomes of the miltuximab first in human trial and proposed study design for a phase 1 trial 89zr/177lu theranostic trial. European Urology Supplements, 18(1), e873. Article 655. https://doi.org/10.1016/S1569-9056(19)30637-2

@article{bad8c7f750e84a0cab422dd9b747517d,

title = "Outcomes of the miltuximab first in human trial and proposed study design for a phase 1 trial 89zr/177lu theranostic trial",

author = "D. Campbell and D. Sabanathan and H. Gurney and D. Gillatt and M. Trifunovic and P. Poursoultan and {Ho Shon}, K. and T. Mackay and P. Roach and D. Bailey and B. Walsh",

year = "2019",

doi = "10.1016/S1569-9056(19)30637-2",

language = "English",

volume = "18",

pages = "e873",

journal = "European Urology Supplements",

issn = "1569-9056",

publisher = "Elsevier",

number = "1",

note = "Annual EAU Congress (34th : 2019), EAU19 ; Conference date: 15-03-2019 Through 19-03-2019",

}

Campbell, D, Sabanathan, D, Gurney, H , Gillatt, D, Trifunovic, M, Poursoultan, P, Ho Shon, K, Mackay, T, Roach, P, Bailey, D & Walsh, B 2019, 'Outcomes of the miltuximab first in human trial and proposed study design for a phase 1 trial 89zr/177lu theranostic trial', European Urology Supplements, vol. 18, no. 1, 655, pp. e873. https://doi.org/10.1016/S1569-9056(19)30637-2

TY - JOUR

T1 - Outcomes of the miltuximab first in human trial and proposed study design for a phase 1 trial 89zr/177lu theranostic trial

AU - Campbell, D.

AU - Sabanathan, D.

AU - Gurney, H.

AU - Gillatt, D.

AU - Trifunovic, M.

AU - Poursoultan, P.

AU - Ho Shon, K.

AU - Mackay, T.

AU - Roach, P.

AU - Bailey, D.

AU - Walsh, B.

PY - 2019

Y1 - 2019

U2 - 10.1016/S1569-9056(19)30637-2

DO - 10.1016/S1569-9056(19)30637-2

M3 - Meeting abstract

SN - 1569-9056

VL - 18

SP - e873

JO - European Urology Supplements

JF - European Urology Supplements

IS - 1

M1 - 655

T2 - Annual EAU Congress (34th : 2019)

Y2 - 15 March 2019 through 19 March 2019

ER -